About Us

We are Committed to being a Collaborative Platform for Innovative Biotech Companies from around the World.

Viva BioInnovator ("VBI") is the investment division of Viva Biotech Holdings (1873.HK). We are solely dedicated to the identification and success of early-stage, biotech start-ups for Viva’s incubation, equity-for-service, and investment platforms. Our commitment is to operate a collaborative platform for innovative biotech companies from around the world, and for anyone aiming to develop an idea with transformative or strong potential.


We invest in some of the most innovative founders to build a unique portfolio covering a wide range of indications and drug types.

  • Riparian Pharmaceuticals,Inc.
  • Dogma Therapeutics, Inc.
  • Tabomedex Biosciences, Inc.
  • Weiqing Biomedicine
  • Flash Therapeutics, LLC
  • Arthrosi Therapeutics, Inc
  • AmacaThera, Inc.
  • Forkhead BioTherapeutics, LLC
  • Anji Pharmaceuticals Inc.
  • Epican Technology Limited
  • Jiaxing Youbo Biotechnology Co., Ltd.
  • Trio Bio,LCC
  • Bonti, INC.
  • Accuracy
  • ABM Therapeutics, Inc.
  • VersaPeutics, Inc.
  • QurAlis Corporation
  • Technoderma
  • Wei Qing biology
  • Zing Bio,LLC
  • Calira Therapeutics LLC
  • Twin Lanterns Bio, LLC
  • Healing organisms
  • Totient Inc.
  • Mediar Therapeutics, Inc.


Read the most up to date information about us and our partners.